| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. | 20% | $37,250,719 | 14,110,121 | Oramed Pharmaceuticals Inc. | 24 Apr 2025 | |||
| Sofer Uzi | 16% | $42,751,366 | 13,702,361 | Uzi Sofer | 31 Dec 2022 |
As of 30 Sep 2025, 31 institutional investors reported holding 1,832,497 shares of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS). This represents 2.1% of the company’s total 86,723,804 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 533,511 | $2,640,880 | +$1,892,306 | $4.95 | 2 |
| 2025 Q3 | 1,832,497 | $8,263,970 | +$1,145,345 | $4.51 | 31 |
| 2025 Q2 | 1,586,693 | $4,950,874 | +$1,313,729 | $3.12 | 24 |
| 2025 Q1 | 1,172,124 | $2,940,869 | +$461,245 | $2.51 | 23 |
| 2024 Q4 | 1,008,266 | $3,125,497 | +$134,426 | $3.10 | 22 |
| 2024 Q3 | 948,076 | $2,228,639 | -$143,072 | $2.38 | 23 |
| 2024 Q2 | 1,296,861 | $3,253,557 | -$1,298,641 | $2.53 | 24 |
| 2024 Q1 | 1,827,730 | $5,350,437 | +$48,533 | $2.95 | 27 |
| 2023 Q4 | 1,840,525 | $5,505,585 | +$2,478,553 | $3.01 | 26 |
| 2023 Q3 | 975,005 | $3,652,424 | +$100,183 | $3.79 | 23 |
| 2023 Q2 | 948,570 | $4,107,472 | +$2,064,199 | $4.37 | 20 |
| 2023 Q1 | 652,086 | $1,871,091 | +$336,132 | $2.87 | 16 |
| 2022 Q4 | 533,823 | $1,697,581 | -$889,137 | $3.18 | 13 |
| 2022 Q3 | 697,266 | $4,011,000 | -$4,736 | $5.84 | 16 |
| 2022 Q2 | 653,675 | $5,920,000 | +$1,784,957 | $9.01 | 13 |
| 2022 Q1 | 447,472 | $5,281,000 | +$5,281,000 | $11.81 | 11 |